These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Cellular features of endometrial hyperplasia and well differentiated adenocarcinoma using the Endocyte sampler: Diagnostic criteria based on the cytoarchitecture of tissue fragments. Norimatsu Y, Shimizu K, Kobayashi TK, Moriya T, Tsukayama C, Miyake Y, Ohno E. Cancer; 2006 Apr 25; 108(2):77-85. PubMed ID: 16463402 [Abstract] [Full Text] [Related]
13. Correlation of cytologic findings and chromosomal instability detected by fluorescence in situ hybridization in breast fine-needle aspiration specimens from women at high risk for breast cancer. Sneige N, Liu B, Yin G, Gong Y, Arun BK. Mod Pathol; 2006 May 25; 19(5):622-9. PubMed ID: 16528376 [Abstract] [Full Text] [Related]
14. Clonal evolution in paired endometrial intraepithelial neoplasia/atypical hyperplasia and endometrioid adenocarcinoma. Russo M, Broach J, Sheldon K, Houser KR, Liu DJ, Kesterson J, Phaeton R, Hossler C, Hempel N, Baker M, Newell JM, Zaino R, Warrick JI. Hum Pathol; 2017 Sep 25; 67():69-77. PubMed ID: 28712776 [Abstract] [Full Text] [Related]
15. Study on the morphology and reproducibility of the diagnosis of endometrial lesions utilizing liquid-based cytology. Papaefthimiou M, Symiakaki H, Mentzelopoulou P, Tsiveleka A, Kyroudes A, Voulgaris Z, Tzonou A, Karakitsos P. Cancer; 2005 Apr 25; 105(2):56-64. PubMed ID: 15751019 [Abstract] [Full Text] [Related]
16. [Detection of chromosome 17 aneuplody and TP53 gene deletion in a broad variety of solid tumors by dual-color fluorescence in situ hybridization (FISH)]. Herrera JC, Isaza LF, Ramírez JL, Vásquez G, Muñetón CM. Biomedica; 2010 Apr 25; 30(3):390-400. PubMed ID: 21713341 [Abstract] [Full Text] [Related]
17. Genetic imbalances in precursor lesions of endometrial cancer detected by comparative genomic hybridization. Kiechle M, Hinrichs M, Jacobsen A, Lüttges J, Pfisterer J, Kommoss F, Arnold N. Am J Pathol; 2000 Jun 25; 156(6):1827-33. PubMed ID: 10854205 [Abstract] [Full Text] [Related]
18. DNA in situ hybridization (interphase cytogenetics) versus comparative genomic hybridization (CGH) in human cancer: detection of numerical and structural chromosome aberrations. Van Dekken H, Krijtenburg PJ, Alers JC. Acta Histochem; 2000 Feb 25; 102(1):85-94. PubMed ID: 10726167 [Abstract] [Full Text] [Related]
19. Numerical abnormalities of chromosomes 1 and 10 in endometrial adenocarcinoma: fluorescence in situ hybridization analysis of 23 archival paraffin-embedded samples. Muresu R, Cossu A, Scarpa AM, Volpi EV, Rocca PC, Pintus A, Tibiletti MG, Tanda F, Pirastu M, Massarelli G. Cancer Genet Cytogenet; 1998 Nov 25; 107(1):37-42. PubMed ID: 9809032 [Abstract] [Full Text] [Related]
20. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Enomoto T, Fujita M, Inoue M, Rice JM, Nakajima R, Tanizawa O, Nomura T. Cancer Res; 1993 Apr 15; 53(8):1883-8. PubMed ID: 8385572 [Abstract] [Full Text] [Related] Page: [Next] [New Search]